On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority.

On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority.
Last Monday, IDL Diagnostics had the honor of attending the diplomatic reception hosted by the Embassy of the Republic of Indonesia to commemorate 81 years of Indonesia's Independence and 76 years of Indonesia–Sweden diplomatic relations. The afternoon brought...
CEO Gustav Sten and CFO Ellen Dittberner present the company’s Q2’26 results – August 20, 2026
We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a...